Dr Monika Skubisz

FRANZCOG,PhD (Medicine), MBBS, Bachelor of Medical Science
Dr Monika Skubisz

Dr Monika Skubisz is a clinician researcher working as a specialist Obstetrician and Gynaecologist at Ashford, the Riverland General and Women's and Children's Hospitals, Research Fellow with the Womenand Kids Theme at SAHMRI and Senior Clinical Lecturer at the University of Adelaide. She is the RANZCOG Research Foundation's Ella Macknight Scholar 2019-2020.

Dr Skubisz completed medical school at the University of Melbourne and a PhD (Medicine) at Monash University, where she conducted clinical trials to improve the management of early pregnancy complications including ectopic and molar pregnancies. She has a special interest in nutritional and preventive medicine and is currently involved in clinical trials looking at the ability of omega 3 to prevent preterm birth and whether Australian women are being exposed to excessive folic acid in later pregnancy. She is on the Executive Committee of the Australian Preterm Birth Prevention Alliance, a national body of experts looking to safely reduce the rate of preterm birth in Australia. Her work has influenced clinical guidelines both nationally and abroad and been published in leading journals in the field. Together with her supervisor and collaborator, Dr Skubisz's work was recognised as one of the Top Ten NHMRC Research Projects in 2015.


2018 Ella Macknight Scholarship, Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Research Foundation, Australia.

2018 Professor Alistair MacLennan AO Award (Excellence in Teaching), University of Adelaide

2016 Ten of the Best Research Projects of 2015, NHMRC

And selected publications:

Simmonds, L., Sullivan, T., Skubisz, M., Middleton, P., Best, K., Yelland, L., Quinlivan, J., Zhou, S., Liu, G., McPhee, A., Gibson, R., Makrides M. 2020. Omega‐3 fatty acid supplementation in pregnancy—baseline omega‐3 status and early preterm birth: exploratory analysis of a randomised controlled trial. BJOG doi: 10.1111/1471-0528.16168

Makrides, M., Best, K., Yelland, L., McPhee, A., Zhou, S., Quinlivan, J., Gibson, R. and the ORIP Investigative Team (Skubisz, M.)2019. Omega-3 long chain polyunsaturated fatty acids to reduce the incidence of pre-term birth. NEJM, 11, 1035-1045.

Skubisz, M., Doust, A., Mollison, J., Johns, T. G., Neil, P., Robinson, M., Bhattacharya, S., Wallace, E. M., Krzys, N., Duncan, W. C., Tong, S., Horne, A. W. 2018. Gefitinib and methotrexate to treat tubal ectopic pregnancies: Phase II open label, single arm multi-centre trial. EBioMedicine, 33, 276–281.

Tong, S., Skubisz, M., Horne, A. 2015. Molecular diagnostics and therapeutics for ectopic pregnancy. Mol Hum Reprod, 21, 126-35.

Horne, A. W.,* Skubisz, M.,* Tong, S., Duncan, W. C., Neil, P., Wallace, E. M. & Johns, T. G. 2014. Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series. Hum Reprod, 29, 1375-9.

Skubisz, M.,* Horne, A. W.,* Johns, T. G., Nilsson, U. W., Duncan, W. C., Wallace, E. M., Critchley, H. O. & Tong, S. 2013. Combination gefitinib and methotrexate compared with methotrexate alone to treat ectopic pregnancy. Obstet Gynecol, 122, 745-751.​

Skubisz, M., Brown, J. K., Tong, S., Kaitu'u-Lino, T. & Horne, A. W. 2013. Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location. PLoS One, 8, e66339.

Skubisz, M., Li, J., Wallace, E. & Tong, S. 2011. Decline in beta hCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study. BJOG, 118, 1665-8.

Skubisz, M.& Tong, S. 2011. Of leaves and butterflies: how methotrexate came to be the savior of women. Obstet Gynecol, 118, 1169-73.

Portal Icon
Find out more about Monika's research outputs, qualifications and affiliations on the SAHMRI Researcher portal